Posters 26 - 29 May, 2019 03. Lipids - 03.10 Novel aspects of dyslipidemia treatment| Volume 287, e206, August 2019

Lipid Lowering Therapies And Cholesterol Levels After St-Segment Elevation Myocardial Infarction: Single Center Experience Of Secondary Prevention

      Background and Aims: Lipid lowering therapies are the mainstay of secondary prevention after myocardial infarction (MI). However, non-adherence to statins is a major problem that leads to off-target LDL-C levels and higher rates of adverse cardiovascular events.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect